← 產業報告目錄
Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based), By Type of Expression System, By Workflow, By Application, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-13頁數 179報告編號 INSIGHTACE-eb6e4ed7b3
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 2.3 Bn as of 2024, the global Vaccine Contract Manufacturing Market is set to climb to USD 3.9 Bn by 2034, reflecting a compound annual growth rate of 6.0% over the 2025–2034 period.
Vaccine Contract Manufacturing encompasses challenges.
Market momentum is driven by rising appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Vaccine Contract Manufacturing Market Snapshot
Chapter 4. Global Vaccine Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Vaccine Contract Manufacturing Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Vaccine Type Estimates & Trend Analysis
5.1. Vaccine Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Vaccine Type:
5.2.1. Avian Expression Systems
5.2.2. Bacterial Expression Systems
5.2.3. Embryonated Chicken Eggs and Primary Chicken Embryonic Fibroblasts (CEFs)
5.2.4. Insect Expression Systems
5.2.5. Mammalian Expression Systems
5.2.6. Plant Expression Systems
5.2.7. Yeast Expression Systems
Chapter 6. Market Segmentation 2: Type of Expression System Estimates & Trend Analysis
6.1. Type of Expression System & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Expression System:
6.2.1. Attenuated
6.2.2. Inactivated
6.2.3. Subunit-based
6.2.4. Toxoid-based
6.2.5. DNA-based
Chapter 7. Market Segmentation 3: Workflow Estimates & Trend Analysis
7.1. Workflow & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Workflow:
7.2.1. Downstream
7.2.2. Upstream
Chapter 8. Market Segmentation 4: Application Estimates & Trend Analysis
8.1. Application & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
8.2.1. Human Use
8.2.2. Veterinary
Chapter 9. Vaccine Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034
9.1.2. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034
9.1.3. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034
9.1.4. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.1.5. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034
9.2.2. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034
9.2.3. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034
9.2.4. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.2.5. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. France
9.2.5.3. Italy
9.2.5.4. Spain
9.2.5.5. UK
9.2.5.6. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034
9.3.2. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034
9.3.3. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034
9.3.4. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.3.5. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034
9.4.2. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034
9.4.3. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034
9.4.4. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.4.5. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. MEA
9.5.1. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034
9.5.2. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034
9.5.3. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034
9.5.4. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.5.5. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.5.5.1. GCC Countries
9.5.5.2. South Africa
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Lonza
10.2.2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
10.2.3. Ajinomoto Althea, Inc.
10.2.4. Merck KgaA
10.2.5. Cytovance Biologics
10.2.6. Catalent, Inc.
10.2.7. IDT Biologika GmbH
10.2.8. Albany Molecular Research, Inc.
10.2.9. PRA Health Sciences
10.2.10. ICON plc.
10.2.11. Pharmaceutical Product Development, LLC
10.2.12. Cobra Bio
10.2.13. Paragon Bioservices, Inc.
10.2.14. Charles River Laboratories
10.2.15. Meridian Life Science (MLS)
10.2.16. Eurogentec
10.2.17. GreenPak Biotech
10.2.18. Hong Kong Institute of Biotechnology
10.2.19. WuXi Biologics
10.2.20. Bharat Biotech
10.2.21. Biological E
10.2.22. Other Prominent Player
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們